Literature DB >> 8750216

The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales.

A Gray1, P Fenn, A McGuire.   

Abstract

This study estimates the direct health and social care costs of insulin-dependent diabetes mellitus (IDDM) in England and Wales in 1992 to be 96 million pounds, or 1021 pounds per person in a population with IDDM estimated at 94,000 individuals. These costs include insulin maintenance, hospitalization, GP and out-patient consultations, renal replacement therapy, and payments to informal carers. Expenditure is concentrated on younger age groups, with one-third of the total expended on those aged 0-24. Around one-half of the total costs can be directly attributed to IDDM, with the remainder associated with a range of complications of the disease. The single largest area of service expenditure is renal replacement therapy. The cost estimates are most sensitive to incidence rates of IDDM, numbers on dialysis and average duration of dialysis. A further 113 million pounds may be lost each year due to premature deaths resulting in lost productive contributions to the economy. The direct and indirect costs of IDDM are therefore significant. The cost of illness framework presented here should facilitate the economic evaluation of new and existing treatment regimens, which may improve value for money by reducing costs and/or increasing the quality or quantity of life for people with IDDM.

Entities:  

Mesh:

Year:  1995        PMID: 8750216     DOI: 10.1111/j.1464-5491.1995.tb00423.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Costs of diabetes. A methodological analysis of the literature.

Authors:  E Pagano; M Brunetti; F Tediosi; L Garattini
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

2.  Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy.

Authors:  L Garattini; M Brunetti; F Salvioni; M Barosi
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

3.  Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.

Authors:  L Govan; O Wu; A Briggs; H M Colhoun; J A McKnight; A D Morris; D W M Pearson; J R Petrie; N Sattar; S H Wild; R S Lindsay
Journal:  Diabetologia       Date:  2011-05-24       Impact factor: 10.122

4.  The economic burden of coronary heart disease in the UK.

Authors:  J L Y Liu; N Maniadakis; A Gray; M Rayner
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

5.  Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).

Authors:  Alastair Gray; Philip Clarke; Andrew Farmer; Rury Holman
Journal:  BMJ       Date:  2002-10-19

6.  The annual societal cost of alcohol misuse in Scotland.

Authors:  Susan J Varney; Julian F Guest
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies.

Authors:  Jen Kruger; Alan Brennan
Journal:  Eur J Health Econ       Date:  2012-10-18

Review 8.  Cost-of-illness studies in diabetes mellitus.

Authors:  Lorraine Ettaro; Thomas J Songer; Ping Zhang; Michael M Engelgau
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Comparative risks of diabetes-related complications of basal insulins: a longitudinal population-based cohort of type 1 diabetes 1999-2013 in Taiwan.

Authors:  Huang-Tz Ou; Tsung-Ying Lee; Ye-Fong Du; Chung-Yi Li
Journal:  Br J Clin Pharmacol       Date:  2017-11-28       Impact factor: 4.335

10.  Economic burden of diabetes mellitus in the WHO African region.

Authors:  Joses M Kirigia; Hama B Sambo; Luis G Sambo; Saidou P Barry
Journal:  BMC Int Health Hum Rights       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.